11 Einträge gefunden

1. Return of individual genomic research results within the PRAEGNANT multicenter registry study

   1. Huebner, Hanna
   2. Ruebner, Matthias
   3. Kurbacher, Christian
   4. Hadji, Peyman
   5. Hartkopf, Andreas D
   6. Lux, Michael P
   7. Huober, Jens

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status

   1. Hein, Alexander
   2. Hartkopf, Andreas D
   3. Emons, Julius
   4. Lux, Michael P
   5. Volz, Bernhard
   6. Taran, Florin-Andrei
   7. Overkamp, Friedrich

   2021 - Forschungsinformationssystem des UKE
3. Challenges and Opportunities for Real-World Evidence in Metastatic Luminal Breast Cancer

   1. Lüftner, Diana
   2. Hartkopf, Andreas D
   3. Lux, Michael P
   4. Overkamp, Friedrich
   5. Tesch, Hans
   6. Titzmann, Adriana
   7. Pöschke, Patrik

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany

   1. Huebner, Hanna
   2. Kurbacher, Christian M
   3. Kuesters, Geoffrey
   4. Hartkopf, Andreas D
   5. Lux, Michael P
   6. Huober, Jens
   7. Volz, Bernhard

   2020 - Forschungsinformationssystem des UKE
5. Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis

   1. Fasching, Peter A
   2. Hartkopf, Andreas D
   3. Gass, Paul
   4. Häberle, Lothar
   5. Akpolat-Basci, Leyla
   6. Hein, Alexander
   7. Volz, Bernhard

   2019 - Forschungsinformationssystem des UKE
6. Update Breast Cancer 2018 (Part 1) - Primary Breast Cancer and Biomarkers

   1. Taran, Florin-Andrei
   2. Schneeweiss, Andreas
   3. Lux, Michael P
   4. Janni, Wolfgang
   5. Hartkopf, Andreas D
   6. Nabieva, Naiba
   7. Overkamp, Friedrich

   2018 - Forschungsinformationssystem des UKE
7. Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention

   1. Schneeweiss, Andreas
   2. Lux, Michael P
   3. Janni, Wolfgang
   4. Hartkopf, Andreas D
   5. Nabieva, Naiba
   6. Taran, Florin-Andrei
   7. Overkamp, Friedrich

   2018 - Forschungsinformationssystem des UKE
8. Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry

   1. Lux, Michael P
   2. Nabieva, Naiba
   3. Hartkopf, Andreas D
   4. Huober, Jens
   5. Volz, Bernhard
   6. Taran, Florin-Andrei
   7. Overkamp, Friedrich

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
9. Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry

   1. Hartkopf, Andreas D
   2. Huober, Jens
   3. Volz, Bernhard
   4. Nabieva, Naiba
   5. Taran, Florin-Andrei
   6. Schwitulla, Judith
   7. Overkamp, Friedrich

   2018 - Forschungsinformationssystem des UKE
10. Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry

    1. Müller, Volkmar
    2. Nabieva, Naiba
    3. Häberle, Lothar
    4. Taran, Florin-Andrei
    5. Hartkopf, Andreas D
    6. Volz, Bernhard
    7. Overkamp, Friedrich

    2018 - Forschungsinformationssystem des UKE
11. Update Breast Cancer 2017 - Implementation of Novel Therapies

    1. Lux, Michael P
    2. Janni, Wolfgang
    3. Hartkopf, Andreas D
    4. Nabieva, Naiba
    5. Taran, Florin-Andrei
    6. Overkamp, Friedrich
    7. Kolberg, Hans-Christian

    2017 - Forschungsinformationssystem des UKE